Do patients benefit from switching to a second biologic drug when the first is withdrawn due to lack of efficacy or adverse events?

Elisabeth Hjardem, Mikkel Østergaard, M.L. Hetland

OriginalsprogEngelsk
Publikationsdato2004
StatusUdgivet - 2004
BegivenhedArthritis Rheum -
Varighed: 18 jul. 2011 → …

Konference

KonferenceArthritis Rheum
Periode18/07/2011 → …

Citationsformater